Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?

Clinical and Experimental Metastasis

Volumn 29, Issue 7, 2012, Pages 687-692

  Giuliano, Armando E ^a   Morrow, Monica ^b   Duggal, Shivani ^c   Julian, Thomas B ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Axilla; Axillary dissection; Biopsy; Breast cancer; Sentinel lymph node

Indexed keywords

AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; CANCER CONTROL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CLINICAL PRACTICE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY;

EID: 84868215324     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9515-z     Document Type: Conference Paper

References (20)

1. Halsted WS (1894) The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Ann Surg 20:497-555
2. Giuliano AE, Kirgan DM, Guenther JM et al. (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-8; discussion 398-401
3. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 305:569-575
4. Fisher B, Jeong JH, Anderson S et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567-575
5. Giuliano AE, Hawes D, Ballman KV et al (2011) Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 306:385-393
6. Wiechmann L, Sampson M, Stempel M et al (2009) Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol 16:2705-2710
7. Moore MP, Kinne DW (1996) Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes. Important Adv Oncol 245-50
8. Clarke D, Newcombe RG, Mansel RE (2004) The learning curve in sentinel node biopsy: The ALMANAC experience. Ann Surg Oncol 11:211S-215S
9. McMasters KM, Wong SL, Chao C et al. (2001) Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: A model for implementation of new surgical techniques. Ann Surg 234:292-9; discussion 299-300
10. Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymphnode resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927-933
11. Ashikaga T, Krag DN, Land SR et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102:111-118
12. Pazaiti A, Fentiman IS (2011) Which patients need an axillary clearance after sentinel node biopsy? Int J Breast Cancer 2011:195892. doi:10.4061/2011/195892
13. Gill G (2009) Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): A randomized controlled surgical trial. Ann Surg Oncol 16:266-275
14. Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Natl Cancer Inst 98:599-609
15. Fisher B, Montague E, Redmond C et al (1980) Findings from NSABP Protocol No. B-04-comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome. Cancer 46:1-13
16. Giuliano AE, McCall L, Beitsch P et al. (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426-32; discussion 432-3
17. Latosinsky S, Berrang TS, Cutter CS et al (2012) CAGS and ACS evidence based reviews in surgery. 40. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis. Can J Surg 55:66-69
18. Tjan-Heijnen VC, de Boer M (2009) Minimal lymph node involvement and outcome of breast cancer. The results of the Dutch MIRROR study. Discov Med 8:137-139
19. Pepels MJ, de Boer M, Bult P et al (2012) Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg 255:116-121
20. Whelan T, Olivotto I, Ackerman J (2011) NCIC-CTG MA.20 an intergroup trial of regional nodal irradiation (RNI) in early stage breast cancer (suppl; Abstr LBA1003). J Clin Oncol 29:80s